Skip to main content
Drug bottle and Pill

Compare Emtriva vs. Videx

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Emtricitabine (Emtriva) and didanosine (Videx) are both antiretroviral (ARV) medications used to treat HIV, and they belong to the same subclass called nucleoside reverse transcriptase inhibitors (NRTIs). However, there are several differences between them. Emtricitabine is still widely used and available in both capsule and oral solution forms, while didanosine has been discontinued in the U.S. due to serious side effects and lack of demand. Emtricitabine is a first-choice medication for HIV treatment and is used in combination with other ARVs, whereas didanosine was one of the first ARVs but is no longer available. Emtricitabine is taken once daily and is known for having fewer side effects, such as nausea and fatigue, while didanosine had more severe side effects, which limited its use. Additionally, emtricitabine requires regular lab tests to monitor kidney and liver function, whereas didanosine had significant drug interaction issues that contributed to its discontinuation.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.